NeuPath Health Inc (NPTH) — Capital Reinvestment Ratio
NeuPath Health Inc (NPTH) has a Capital Reinvestment Ratio of 0.37x as of December 2025, meaning it reinvests 0% of its operating cash flow (CA$662.00K) in capital expenditures (CA$245.00K). Check NPTH tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
NeuPath Health Inc Capital Reinvestment Ratio (2021–2025)
This chart tracks NeuPath Health Inc's Capital Reinvestment Ratio across 5 annual periods. For the full cash flow conversion analysis, see NeuPath Health Inc (NPTH) cash conversion ratio.
Annual Capital Reinvestment Ratio for NeuPath Health Inc (2021–2025)
Year-by-year Capital Reinvestment Ratio for NeuPath Health Inc from 2021 to 2025. See NPTH free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.22x | CA$4.00 Million | CA$863.00K | ▼ -40.7% |
| 2024 | 0.36x | CA$2.61 Million | CA$948.00K | ▲ +212.1% |
| 2023 | 0.12x | CA$3.03 Million | CA$353.00K | ▼ -93.0% |
| 2022 | 1.67x | CA$738.00K | CA$1.23 Million | ▲ +679.4% |
| 2021 | 0.21x | CA$1.92 Million | CA$411.00K | — |